Genomics & epigenomics in multiple myeloma: key updates and potential clinical applications

0 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
In this discussion, experts Gareth Morgan, MD, PhD, FRCP, FRCPath, NYU Langone, New York City, NY, Benjamin Barwick, PhD, Winship Cancer Institute of Emory University, Atlanta, GA, and Lawrence Boise, PhD, Winship Cancer Institute of Emory University, Atlanta, GA, discuss the value of genomics and epigenomics in multiple myeloma. They share insights into the genomic changes involved in high-risk disease, ongoing research in the field, the potential of inhibiting NSD2, and what this may mean for clinical practice. This session was filmed at the 18th International Workshop on Multiple Myeloma (iwMyeloma), held in Miami, FL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Category
Oncology
Be the first to comment

Up Next